Dental service organization and consulting company apZme launches apZme Dx, a new type IV home testing device and artificial intelligence (AI)-powered mobile app developed in collaboration with Millennium Sleep Lab, an apZme company.
ApZme Dx is a wrist-worn type IV testing device that uses signals from familiar pulse oximeters and employs AI-driven analysis to detect respiratory events—including apnea-hypopnea index, respiratory disturbance index, and hypoxic burden—and to identify sleep stages such as wake, light sleep, deep sleep, and REM. The app immediately transfers the data for physician review.
“At apZme, our mission is to lead the way in innovating dental sleep medicine and bring accessible, effective sleep health solutions to patients everywhere,” says Rani Ben-David, founder and CEO of apZme, in a release. “With apZme Dx, we’re making a powerful step forward by making sleep diagnostics easier, faster, and more convenient than ever.”
According to the company, the app’s features are designed to ensure inclusivity and accuracy, with no performance bias in relation to skin color. The platform also centralizes data management across multiple devices, creating a streamlined process for clinicians and enabling multinight testing to provide a fuller picture of patient sleep patterns.
“The launch of apZme Dx represents apZme’s commitment to advancing sleep health. By centralizing device data, facilitating easier clinician access, and accelerating treatment, we are delivering high-quality, patient-centered care,” says Kent Smith, DDS, D-ABDSM, CEO of Star Sleep & Wellness, and co-founder and president of apZme, in a release.
“The release of apZme Dx underscores apZme’s pursuit of innovation as we continue to lead the field in dental sleep medicine,” says Jeff Scholtes, CEO of Millennium Sleep Lab, an apZme company, in a release.
